Ann: MYX and GoodRx announce NEXTSTELLIS DTC campaign, page-5

At least the SP is going in the right direction. It’s been a hell of a long time since anything these guys have done has turned out to be a profitable venture apart from Metrics. I believe that they have gambled literally with share holders funds trying to buy a profit, with somebody else’s failure. The generic business that they bought cost most of us 80% of our share value, write down after write down turning any profits into losses. Each report from the last 5 years has had excuses, about competition and government crackdowns on genetics pharmacy cartels controlling pricing, moving away from the 70 products they paid massive amounts of money for.


with them moving away from the generic products, and if they could show a profit for a change the share price may have a chance of further recovery. Myring was also supposed to be the white knight, the turn around, also generic.
Im not sure we ever made half of what we paid for the suite of rubbish. Not sure what our 500 paid scientists do, we haven’t come up with anything of substance.

I believe poor leadership has been the catalyst for continual failure and until it changes we are going nowhere.
The next report will be full of excuses and carrot dangling, I’m sure he is the poison that’s stopping this from growing. This next venture will still be shrouded with underachievement and be rewarded with more lowball performance bonuses.

Anyway, could have won and lost a million dollars, in the time it will take for a breakeven on this stock.
Hope this does turn around but not holding my breath or buying more.
Good luck all.
This is my opinion and DYOR.